A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the

The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.

Testing large numbers of people regularly would reduce the spread of the coronavirus in the US. Laboratory testing is slow and expensive, but rapid screening tests could be the answer.

Test positivity rates measure the success of a testing program. Even though the US performs a huge number of tests, high test positivity rates across the country show that that it still isn't enough.

A team of researchers from Indiana University performed random testing for SARS-CoV-2 across the state. The results offer some of the most accurate data to date about important aspects of the virus.

Screening multiple samples with a single test gets more people diagnosed using fewer supplies. Two health policy researchers explain how it works and how it could help the U.S.

It's nearly impossible to avoid close contact when protesting, and easy to forget the risks. An infectious disease expert answers key questions about how to avoid spreading the coronavirus to family.

An antigen test was given emergency use authorization by the FDA in early May. A biochemist explains how COVID-19 antigen tests work.

An outpouring of volunteers and equipment from the Harvard medical community have helped a Harvard hospital testing lab meet COVID’s challenge.

Expanding coronavirus testing is one of the most important tasks public health officials are tackling right now. But questions over accuracy of the two main types of tests have rightly caused concern.